Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02247765 · ClinicalTrials.gov registry record · Phase 3
Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion
A Phase 3 study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- Phase 3
- Development phase
- 18
- Enrollment target
NCT02247765 is a Phase 3 study that has completed, run by Medtronic - MITG. The registered enrollment target is 18 participants.
The verdict
NCT02247765, a Phase 3 study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 18 participants
- Enrollment target
Study Summary
To validate the proposed claims for pulse rate and saturation accuracy in a diverse subject population during motion over a specified saturation range.
Interventions
- DEVICE Arterial line
- DEVICE Motion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02247765
The ClinicalTrials.gov registry entry for NCT02247765 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arterial line is the first listed.
NCT02247765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02247765 about?
NCT02247765 is a clinical study titled "Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion". To validate the proposed claims for pulse rate and saturation accuracy in a diverse subject population during motion over a specified saturation range.
What is the current status of trial NCT02247765?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 18 participants. The study started on 2014-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02247765?
The interventions under investigation include: Arterial line (DEVICE), Motion (DEVICE).
Who is sponsoring clinical trial NCT02247765?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.